Rare diseases
Investigational molecules
Locations
Back to Iceland5 clinical trials in Kopavogur, Iceland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in IcelandKliniskarRannsoknir.is(opens in a new tab)IcelandA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
IcelandStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
IcelandStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
IcelandStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
IcelandThe busiest research cities in the country
What the registry says about research in the country
Investigating new therapeutic approaches for cardiovascular disease, focusing on innovative treatments to reduce major cardiovascular events in high-risk patients.
Studies aim to evaluate novel compounds that target specific cardiovascular risk factors and improve patient outcomes.
Clinical research focusing on atherosclerotic cardiovascular disease and innovative approaches to prevent serious cardiovascular complications.
Evaluating cutting-edge treatments to reduce the risk of heart attacks, strokes, and cardiovascular mortality.
Research focusing on treating fungal nail infections in young patients, exploring safe and effective therapeutic solutions for children aged 6-17 years.
Studies evaluate innovative external treatments designed specifically for younger populations with nail conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
